Adiponectin, Resistin and Leptin Response to Dietary Intervention in Diabetic Nephropathy

Journal of Renal Nutrition

Volumn 20, Issue 4, 2010, Pages 255-262

  Kozłowska, Lucyna ^a   Rydzewski, Andrzej ^b,c   Fiderkiewicz, Bartosz ^b   Wasińska Krawczyk, Anna ^b   Grzechnik, Agnieszka ^a   Rosołowska Huszcz, Danuta ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^c JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010096     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.01.009     Document Type: Article

References (44)

1. Arita, Y., Kihara, S., Ouchi, N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999), 79–83.
2. Hu, E., Liang, P., Spiegelman, B.M., AdipoQ is a novel adipose-specific gene dysregulated in adiposity. J Biol Chem 271 (1996), 10697–10703.
3. Statnick, M.A., Beavers, L.S., Conner, L.J., et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diab Res 1 (2000), 81–88.
4. Yamauchi, T., Kamon, J., Waki, H., et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001), 941–946.
5. Ouchi, N., Kihara, Y., Arita, Y., et al. Adiponectin, an adipocyte derived plasma protein inhibits endothelial NF-κB signaling through a cAMP dependent pathway. Circulation 102 (2000), 1296–1301.
6. Ouchi, N., Kihara, S., Arita, Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein, adiponectin. Circulation 100 (1999), 2473–2476.
7. Zhang, J.L., Qin, Y.W., Zheng, X., et al. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 20 (2003), 828–831.
8. Mojiminiyi, O.A., Abdella, N.A., Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 67 (2007), 215–225.
9. Silha, J.V., Krsek, M., Skrha, J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149 (2003), 331–335.
10. Osawa, H., Ochi, M., Kato, K., et al. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes. Biochem Biophys Res Commun 355 (2007), 342–346.
11. Shimomura, J., Hammer, R.E., Ikemoto, S., et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401 (1999), 73–76.
12. Lee, J.H., Reed, D.R., Price, R.A., Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 25 (2001), 1471–1473.
13. Maedler, K., Schulthess, F.T., Bielman, C., et al. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J 22 (2008), 1905–1913.
14. Saito, T., Saito, O., Kawano, T., et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabet Res Clin Pract 78 (2007), 85–92.
15. Lin, J., Hu, F.B., Curhan, G., Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabet Care 30 (2007), 239–244.
16. Axelsson, J., Bergsten, A., Qureshi, A.R., et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69 (2006), 596–604.
17. Menon, V., Wang, X., Greene, T., et al. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol 61 (2004), 163–169.
18. Shoji, T., Emoto, M., Nishizawa, Y., HOMA index to assess insulin resistance in renal failure patients. Nephron 89 (2001), 348–349.
19. Levey, A.S., Bosch, J.P., Lewis, J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 16 (1999), 461–470.
20. Yannakoulia, M., Yiannakouris, N., Bluher, S., et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003), 1730–1736.
21. Schaffler, A., Buchler, C., Muller-Landner, U., et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 36 (2004), 702–707.
22. Bokarewa, M., Nagaev, I., Dahlberg, L., et al. Resistin, an adipokine with potent antiinflammatory properties. J Immunol 174 (2005), 5789–5795.
23. Nagayev S, Bokarewa M, Tarkowski A, et al: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE, e31:1–9, 2006.
24. Axelsson, J., M⊘ller, H.J., Witasp, A., et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 48:6 (2006), 916–925.
25. Mora, C., Navarro, J.F., Inflammation and diabetic nephropathy. Curr Diab Rep 6:6 (2006), 463–468.
26. Zimmermann, J., Herrlinger, S., Pruy, A., et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999), 648–658.
27. Bergström, J., Lindholm, B., Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis 32:5 (1998), 834–841.
28. Balage, M., Averous, J., Rémond, D., et al. Presence of low-grade inflammation impaired postprandial stimulation of muscle protein synthesis in old rats. J Nutr Biochem, 13, 2009.
29. Rieu, I., Magne, H., Savary-Auzeloux, I., et al. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol Sep, 14, 2009.
30. Bottner, A., Kratzsch, J., Muller, G., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89 (2004), 4053–4061.
31. Couillard, C., Mauriege, P., Prud'homme, D., et al. Plasma leptin concentrations: gender differences and associations with met abolic risk factors for cardiovascular disease. Diabetologia 40 (1997), 1178–1184.
32. Isobe, T., Saitoh, S., Takagi, S., et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 153 (2005), 91–98.
33. Isidori, A.M., Strollo, F., More, M., Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 85 (2000), 1954–1962.
34. Weyer, C., Funahashi, T., Tanaka, S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001), 1930–1935.
35. Lu, H.L., Wang, H.W., Zhang, M.X., et al. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 12 (2006), 1747–1751.
36. Ryan, A.S., Nicklas, B.J., Berman, D.M., et al. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 27 (2003), 1066–1071.
37. Giannopoulou, I., Fernhall, B., Carhart, R., et al. Effects of diet and /or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 54 (2005), 866–875.
38. Abbasi, F., Lamendola, C., McLaughlin, T., et al. Plasma adiponectin concentration do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism 53 (2004), 280–283.
39. Yang, W.S., Lee, W.J., Funahashi, T., et al. Weight reduction increase plasma levels of an adipose derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001), 3815–3819.
40. Faraj, M., Havel, P.J., Phelis, S., et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88 (2003), 1594–1602.
41. Kozłowska, L., Rosołowska-Huszcz, D., Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit. Endocrine 24 (2004), 147–153.
42. Polson, D.A., Thompson, M.P., Macronutrient composition of the diet differentially affects leptin and adiponutrin mRNA expression in response to meal feeding. J Nutr Biochem 15 (2004), 242–246.
43. Santoro, D., Low-protein diet and proteinuria. G Ital Nefrol 25 (2008), 18–24.
44. Kozłowska, L., Rosołowska-Huszcz, D., Rydzewski, A., Low protein diet causes a decrease in serum concentrations of leptin and tumour necrosis factor-alpha in patients with conservatively treated chronic renal failure. Nephrology (Carlton) 9 (2004), 319–324.